RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $83,000 | -1.2% | 29,644 | 0.0% | 0.00% | – |
| Q4 2020 | $84,000 | +35.5% | 29,644 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -54.1% | 29,644 | 0.0% | 0.00% | – |
| Q2 2020 | $135,000 | -44.2% | 29,644 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $242,000 | -57.1% | 29,644 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $564,000 | +68.9% | 30,749 | +1.9% | 0.00% | 0.0% |
| Q3 2019 | $334,000 | +11.3% | 30,178 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $300,000 | +81.8% | 29,490 | +4.7% | 0.00% | – |
| Q1 2019 | $165,000 | -17.5% | 28,164 | 0.0% | 0.00% | – |
| Q4 2018 | $200,000 | +5.3% | 28,164 | +5.5% | 0.00% | – |
| Q3 2018 | $190,000 | +41.8% | 26,704 | 0.0% | 0.00% | – |
| Q2 2018 | $134,000 | -42.2% | 26,704 | +26.9% | 0.00% | – |
| Q1 2018 | $232,000 | +16.0% | 21,041 | -2.6% | 0.00% | – |
| Q4 2017 | $200,000 | -0.5% | 21,600 | -3.6% | 0.00% | – |
| Q3 2017 | $201,000 | +18.9% | 22,400 | -7.1% | 0.00% | – |
| Q2 2017 | $169,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |